Cargando…
Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study
BACKGROUND: HIV infection has become a chronic disease and well-being of people living with HIV (PLHIV) is now of particular concern. The objectives of this paper were to describe self-rated health among PLHIV, on ART and on ART virally suppressed and to analyse its determinants. METHODS: Data were...
Autores principales: | Ruiz-Algueró, Marta, Hernando, Victoria, Marcos, Henar, Gutiérrez, Gonzalo, Pérez-Elías, Maria Jesus, López-Bernaldo de Quirós, Juan Carlos, Pulido, Federico, Górgolas, Miguel, Sanz, Jesus, Suarez-García, Ines, Fernandez, Maria Teresa, Losa, Juan Emilio, Pérez, Jose Luis, Ladrero, Maria Oliva, Prieto, Miguel Ángel, González, Gustavo, Izquierdo, Ana, Viloria, Luis Javier, López, Irene, Martínez, Eva, Castrillejo, Daniel, Aranguren, Rosa, Belmonte, Maria Antonia, Aranda-García, I V, Arraiza, Antonio, Diaz, Asuncion |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847002/ https://www.ncbi.nlm.nih.gov/pubmed/33516173 http://dx.doi.org/10.1186/s12879-021-05815-3 |
Ejemplares similares
-
Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study
por: Suárez-García, Inés, et al.
Publicado: (2020) -
Temporal Trends and Geographic Variability in the Prescription of Antiretroviral Treatments in People Living with HIV in Spain, 2004–2020
por: Ruiz-Algueró, Marta, et al.
Publicado: (2022) -
Peripheral T follicular helper Cells Make a Difference in HIV Reservoir Size between Elite Controllers and Patients on Successful cART
por: García, Marcial, et al.
Publicado: (2017) -
Estimates of mpox effective reproduction number in Spain, April–August 2022
por: García-García, David, et al.
Publicado: (2023) -
48-Week effectiveness and tolerability of dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naïve adults living with HIV: A multicenter real-life cohort
por: Cabello-Ubeda, Alfonso, et al.
Publicado: (2022)